NAT-TERIFLUNOMIDE
Identification of Nat-Teriflunomide
| No description |
Google image searchProduct monograph
Active ingredient
teriflunomide, 14 MG
DIN: 02500310
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 16-MAY-2022
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AK — Dihydroorotate dehydrogenase (DHODH) inhibitors (ATC, ATC/DDD)
- L04AK02 — TERIFLUNOMIDE (ATC/DDD)
Reference brand drug: Aubagio
